Sofyan Hidayatulloh
Docking Molecular Simulation of Secondary Metabolic Compounds Annona Muricata
as Anti-Cancer 1197
Cancer is a major public health problem worldwide and the second leading cause
of death in the United States. In 2017, the American Cancer Society (ACS) estimated the
number of cancer cases was 1.68 million with 4,600 new cancer diagnoses per day and
600,920 cancer deaths (Siegel et al., 2017). Nationally, the prevalence of cancer in people
of all ages in Indonesia in 2013 was 1.4‰ or an estimated 347,792 people, while for East
Java Province it was 61,230 people (Rio and Suci, 2017).
COX-2 is an enzyme that plays a role in the metabolism of arachidonic acid in
cell membranes. Arachidonic acid metabolism is considered to play a very important role
in the occurrence of carcinogenesis. This metabolic pathway is associated with the
formation of prostanoids. Prostanoids belong to the subclass of eicosanoids which are
converted into prostaglandins, thromboxane and prostacyclin (Singh et al., 2010).
Cyclooxsigenase-2 (COX-2) is a key enzyme in the conversion of arachidonic acid to
prostaglandins which was first identified 20 years ago. Several studies have suggested the
involvement of prostanoids in the pathogenesis of cancer (Grösch et al., 2006, p. 2). In
vitro studies have shown that growth factors, tumor promoters and oncogenes induce
prostanoid synthesis (Singh et al., 2010). Other studies, through in vivo studies, have
shown that arachidonic acid metabolism via the cyclooxygenase pathway is increased in
some tumor events in humans and is thought to be mediated by the induction of the COX-
2 enzyme (Chen et al., 2018; Kern et al., 2006).
The most successful therapies for localized and non-metastatic cancers are
surgery and radiotherapy, but they are not effective if the cancer has spread throughout
the body. Cancer treatments (Chemotherapy, hormone, and biologic therapy) can reach
any organ in the body infected by cancer cells. through the bloodstream. Until now these
drugs are the best treatment of choice for metastatic cancer (Chabner and Roberts, 2005).
Chemotherapy treatment for cancer still has a drawback that besides destroying cancer
cells, it also affects normal cells with high growth rates, such as hair follicles, bone
marrow, and gastrointestinal tract cells, causing side effects typical of chemotherapy.
Because of this, it is necessary to find new treatments that selectively kill cancer cells
without affecting normal cells.
The Annona muricata tree, similar to other Annona species, including Annona
squamosa and Annona reticulata is widely used as traditional medicine for various
diseases, especially cancer and parasitic infections. Phytochemical tests state that
annonaceous acetogenins are the main constituents of Annona muricata
(Moghadamtousi, et al., 2015). In addition to annonaceous acetogenin, phytochemical
screening results from aqueous and ethanol extracts of soursop leaves contain secondary
metabolites such as alkaloids, saponins, terpenoids, flavonoids, coumarins, lactones,
anthraquinones, tannins, cardiac glycosides, phenols and phytosterols (Gavamukulya, et
al., 2014). Zetolite and Annonaceous acetogenin are the main ingredients in the soursop
tree, which have anti-cancer, anti-inflammatory, neuroprotective, anti-Alzheimer's and
anti-oxidant activities (Adri and Hersoelistyorini, 2013). Knowing the affinity and
molecular mechanism of Annona muricata to the COX-2 target protein, can be used to
test the potential of Annona muricata as an anticancer drug using the molecular docking
in silico method (Computer modeling). By identifying and optimizing guide molecules in
the drug discovery process, this computational chemical technique can be utilized to
accelerate the selection of compounds to be isolated and synthesized. As a result, it will
be known the ability of Annona muricata to suppress COX-2 receptor overexpression.
RESEARCH METHOD
The research used descriptive quantitative as a research design and the